HealthCare Global Enterprises Ltd has acquired a 12% equity stake in International Stemcell Services Ltd (ISSL) – a stem cell and regenerative medicine research company based in Bengaluru. HealthCare Global, has acquired 10,860 equity shares of ISSL for Rs 56 lakh in an all-cash deal.
HCG said that ISSL is a knowledge centric company in the space of stem cells and regenerative medicine. The developments in healthcare of late have established value of regenerative medicine, offering new found hope to patients. “There is synergy with the hospital in using adult stem cells in treating several conditions including cancer. The research activities with respect to stem cells and regenerative medicine carried out by ISSL would support HCG in the development of targeted therapies for cancer treatment,” HCG said.
In January this year, Healthcare Global Enterprises,had merged Triesta Sciences business unit with Strand Life Sciences Pvt. Ltd.
